Historical perspective on folic acid and challenges in estimating global prevalence of neural tube defects

Annals of the New York Academy of Sciences

Volumn 1414, Issue 1, 2018, Pages 20-30

  Kancherla, Vijaya ^a   Black, Robert E ^b  

^a EMORY UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

anencephaly; neural tube defects; prevalence; spina bifida; surveillance

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ANENCEPHALUS; DRUG USE; ENCEPHALOCELE; GEOGRAPHY; HEALTH CARE ACCESS; HEREDITY; HUMAN; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; NEURAL TUBE DEFECT; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PREVALENCE; REVIEW; RISK FACTOR; SOCIOECONOMICS; SPINAL DYSRAPHISM; SYSTEMATIC REVIEW;

EID: 85048976760     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.13601     Document Type: Review

References (50)

1. Botto, L.D., C.A. Moore, M.J. Khoury, et al. 1999. Neural-tube defects. N. Engl. J. Med. 341: 1509–1519.
2. Bower, C., H. D'Antoine & F.J. Stanley. 2009. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification. Birth Defects Res. A Clin. Mol. Teratol. 85: 269–273.
3. WHO/CDC/ICBDSR. 2014. Birth defects surveillance: atlas of selected congenital anomalies. Geneva: World Health Organization.
4. Parker, S.E., M.M. Yazdy, A.A. Mitchell, et al. 2014. A description of spina bifida cases and co-occurring malformations, 1976–2011. Am. J. Med. Genet. A 164A: 432–440.
5. Christianson, A.L., C.P. Howson & B. Modell. 2006. Global report on birth defects: the hidden toll of dying and disabled children. March of Dimes Birth Defects Foundation, White Plains, NY.
6. Blencowe, H., V. Kancherla, S. Moorthie, et al. 2018. Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann. N.Y. Acad. Sci. 1414: 31–46.
7. Zaganjor, I., A. Sekkarie, B.L. Tsang, et al. 2016. Describing the prevalence of neural tube defects worldwide: a systematic literature review. PLoS One 11: e0151586.
8. Susser, E., H.W. Hoek & A. Brown. 1998. Neurodevelopmental disorders after prenatal famine: the story of the Dutch Famine Study. Am. J. Epidemiol. 147: 213–216.
9. Renwick, J.H. 1972. Spina bifida, anencephaly, and potato blight. Lancet 2: 967–968.
10. Smith, C., M. Watt, A.E. Boyd, et al. 1973. Anencephaly, spina bifida, and potato blight in the Edinburgh area. Lancet 1: 269.
11. MacMahon, B., S. Yen & K.J. Rothman. 1973. Potato blight and neural-tube defects. Lancet 1: 598–599.
12. Lanska, D.J. 2010. Historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins. Handb. Clin. Neurol. 95: 445–476.
13. Czeizel, A.E. 1995. Nutritional supplementation and prevention of congenital abnormalities. Curr. Opin. Obstet. Gynecol. 7: 88–94.
14. McPartlin, J., A. Halligan, J.M. Scott, et al. 1993. Accelerated folate breakdown in pregnancy. Lancet 341: 148–149.
15. Hibbard, B.M. 1964. The role of folic acid in pregnancy; with particular reference to anaemia, abruption and abortion. J. Obstet. Gynaecol. Br. Commonw. 71: 529–542.
16. Elwood, J.H. & N.C. Nevin. 1973. Anencephalus and spina bifida in Belfast (1964–1968). Ulster Med. J. 42: 213–222.
17. Frecker, M. & F.C. Fraser. 1987. Epidemiological studies of neural tube defects in Newfoundland. Teratology 36: 355–361.
18. Elwood, J.H. & M.J. Scott. 1982. Prevalence of anencephalus in the United Kingdom. Dev. Med. Child Neurol. 24: 394–395.
19. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131–137.
20. Cordero, A.M., K.S. Crider, L.M. Rogers, et al. 2015. Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. MMWR Morb. Mortal. Wkly. Rep. 64: 421–423.
21. Crider, K.S., O. Devine, L. Hao, et al. 2014. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ 349: g4554.
22. Williams, J., C.T. Mai, J. Mulinare. et al. 2015. Updated estimates of neural tube defects prevented by mandatory folic acid fortification—United States, 1995–2011. MMWR Morb. Mortal. Wkly. Rep. 64: 1–5.
23. De Wals, P., P. Tairou, M.I. Van Allen, et al. 2007. Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 357: 135–142.
24. Castilla, E.E., I.M. Orioli, J.S. Lopez-Camelo, et al. 2003. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am. J. Med. Genet. A 123A: 123–128.
25. Castillo-Lancellotti, C., J.A. Tur & R. Uauy. 2013. Impact of folic acid fortification of flour on neural tube defects: a systematic review. Public Health Nutr. 16: 901–911.
26. Bhide, P., G.S. Sagoo, S. Moorthie, et al. 2013. Systematic review of birth prevalence of neural tube defects in India. Birth Defects Res. A Clin. Mol. Teratol. 97: 437–443.
27. Moore, C.A., S. Li, Z. Li, et al. 1997. Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am. J. Med. Genet. 73: 113–118.
28. Rosenthal, J., J. Casas, D. Taren, et al. 2014. Neural tube defects in Latin America and the impact of fortification: a literature review. Public Health Nutr. 17: 537–550.
29. Atta, C.A., K.M. Fiest, A.D. Frolkis, et al. 2016. Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis. Am. J. Public Health 106: e24–e34.
30. Khoshnood, B., M. Loane, H. de Walle, et al. 2015. Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ 351: h5949.
31. Botto, L.D., L. Alessandra, C. Bower, et al. 2006. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res. A Clin. Mol. Teratol. 76: 693–705.
32. Berry, R.J., Z. Li, J.D. Erickson, et al. 1999. Prevention of neural-tube defects with folic acid in China. China–U.S. Collaborative Project for Neural Tube Defect Prevention. N. Engl. J. Med. 341: 1485–1490.
33. Rosenthal, J., M.E. Reeve, N. Ramirez, et al. 2016. Red blood cell folate insufficiency among nonpregnant women of childbearing age in Guatemala 2009 to 2010: prevalence and predicted neural tube defects risk. Birth Defects Res. A Clin. Mol. Teratol. 106: 587–595.
34. Botto, L.D. & Q. Yang. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol. 151: 862–877.
35. Tsang, B.L., O.J. Devine, A.M. Cordero, et al. 2015. Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis of trials and observational studies. Am. J. Clin. Nutr. 101: 1286–1294.
36. Yan, L., L. Zhao, Y. Long, et al. 2012. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case–control studies. PLoS One 7: e41689.
37. Zhang, T., I. Lou, R. Zhing, et al. 2013. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature. PLoS One 8: e59570.
38. Yadav, U., P. Kumar, S.K. Yadav, et al. 2015. Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis. Metab. Brain Dis. 30: 7–24.
39. Hamner, H.C. & S.C. Tinker. 2014. Fortification of corn masa flour with folic acid in the United States: an overview of the evidence. Ann. N.Y. Acad. Sci. 1312: 8–14.
40. Cawley, S., L. Mullaney, A. McKeating, et al. 2016. Knowledge about folic acid supplementation in women presenting for antenatal care. Eur. J. Clin. Nutr. 70: 1285–1290.
41. Cawley, S., L. Mullaney, A. McKeating, et al. 2016. A review of European guidelines on periconceptional folic acid supplementation. Eur. J. Clin. Nutr. 70: 143–154.
42. Friberg, A.K. & F.S. Jorgensen. 2015. Few Danish pregnant women follow guidelines on periconceptional use of folic acid. Dan. Med. J. 62: pii: A5019.
43. Darmstadt, G.L., C.P. Howson, G. Walraven, et al. 2016. Prevention of congenital disorders and care of affected children: a consensus statement. JAMA Pediatr. 170: 790–793.
44. WHO/CDC/ICBDSR. 2014. Birth defects surveillance: a manual for programme managers. Geneva. World Health Organization.
45. Lawn, J.E., H. Blencowe, P. Waiswa, et al. 2016. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet 387: 587–603.
46. EUROCAT system. Accessed August 18, 2017. http://www.eurocat-network.eu/.
47. McDonnell, R., V. Delany, M.T. O'Mahony, et al. 2015. Neural tube defects in the Republic of Ireland in 2009–11. J. Public Health 37: 57–63.
48. Daly, L.E., P.N. Kirke, A. Molloy, et al. 1995. Folate levels and neural tube defects. Implications for prevention. JAMA 274: 1698–1702.
49. Arth, A., V. Kancherla, H. Pachon, et al. 2016. A 2015 global update on folic acid-preventable spina bifida and anencephaly. Birth Defects Res. A Clin. Mol. Teratol. 106: 520–529.
50. Grosse, S.D., R.J. Berry, J.M. Tilford, et al. 2016. Retrospective assessment of cost savings from prevention: folic acid fortification and spina bifida in the U.S. Am. J. Prev. Med. 50 (5 Suppl. 1) S74–S80.